3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Association between apolipoprotein B/A1 ratio and coronary plaque vulnerability in patients with atherosclerotic cardiovascular disease: an intravascular optical coherence tomography study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Apolipoprotein (Apo) A1 and Apo B are strongly associated with the risk of atherosclerotic cardiovascular disease (ASCVD). However, the relationship between the Apo B/A1 ratio and the morphology of coronary vulnerable plaques has not been fully elucidated in patients with ASCVD.

          Methods

          A total of 320 patients with ASCVD undergoing percutaneous coronary intervention were enrolled and assigned into acute coronary syndrome (ACS) or chronic coronary syndrome (CCS) group. The morphology of culprit plaque was analyzed by intravascular optical coherence tomography. Association between the Apo B/A1 ratio and coronary vulnerable plaques were evaluated using logistic regression models and receiver operator characteristic (ROC) curve analyses.

          Results

          The Apo B/A1 ratio was higher in ACS patients than CCS patients (0.77 ± 0.28 vs. 0.64 ± 0.22, P < 0.001) and it was also higher in patients with plaque rupture, erosion or thrombus than those without culprit plaques. The high Apo B/A1 ratio was associated with high percent of vulnerable plaques compared with low ratio group. The Apo B/A1 ratio was negatively related to fibrous cap thickness in lipid-rich plaque (r = − 0.228, P = 0.043). Univariate and multivariate logistic regression analyses revealed that the Apo B/A1 ratio was an independent factor of plaque rupture, erosion, and thrombus. The area under the ROC curve of the Apo B/A1 ratio for plaque rupture, erosion, and thrombus were 0.632, 0.624, and 0.670 respectively (P < 0.001 for all), which were higher than that of low-density lipoprotein cholesterol.

          Conclusions

          The Apo B/A1 ratio is an independent predictor for plaque rupture, erosion, and thrombus in patients with ASCVD.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s12933-021-01381-9.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: not found
          • Article: not found

          2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Lessons From Sudden Coronary Death

              Arteriosclerosis, Thrombosis, and Vascular Biology, 20(5), 1262-1275
                Bookmark

                Author and article information

                Contributors
                wjq2018@hotmail.com
                lecross@163.com
                xnkjiangwei@163.com
                Journal
                Cardiovasc Diabetol
                Cardiovasc Diabetol
                Cardiovascular Diabetology
                BioMed Central (London )
                1475-2840
                15 September 2021
                15 September 2021
                2021
                : 20
                : 188
                Affiliations
                GRID grid.452672.0, Department of Cardiology, , The Second Affiliated Hospital of Xi’an Jiaotong University, ; Xiwulu 157#, Xi’an, 710004 Shaanxi China
                Author information
                http://orcid.org/0000-0002-2204-9839
                Article
                1381
                10.1186/s12933-021-01381-9
                8442358
                34526013
                f42d1ad8-9d1b-458a-bd1d-ba5e2c0a39a3
                © The Author(s) 2021

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 15 July 2021
                : 7 September 2021
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100007128, natural science foundation of shaanxi province;
                Award ID: 2021JM-291
                Award Recipient :
                Categories
                Original Investigation
                Custom metadata
                © The Author(s) 2021

                Endocrinology & Diabetes
                optical coherence tomography,atherosclerotic cardiovascular disease,apolipoprotein

                Comments

                Comment on this article